Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Improving wellbeing and reducing future world population.

ABSTRACT: Almost 80% of the 4 billion projected increase in world population by 2100 comes from 37 Mid-African Countries (MACs), caused mostly by slow declines in Total Fertility Rate (TFR). Historically, TFR has declined in response to increases in wellbeing associated with economic development. We show that, when Infant Survival Rate (ISR, a proxy for wellbeing) has increased, MAC fertility has declined at the same rate, in relation to ISR, as it did in 61 comparable Other Developing Countries (ODCs) whose average fertility is close to replacement level. If MAC ISR were to increase at the historic rate of these ODCs, and TFR declined correspondingly, then the projected world population in 2100 would be decreasing and 1.1 billion lower than currently projected. Such rates of ISR increase, and TFR decrease, are quite feasible and have occurred in comparable ODCs. Increased efforts to improve the wellbeing of poor MAC populations are key.

SUBMITTER: Murdoch WW

PROVIDER: S-EPMC6135380 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Improving wellbeing and reducing future world population.

Murdoch William W WW Chu Fang-I FI Stewart-Oaten Allan A Wilber Mark Q MQ

PloS one 20180912 9

Almost 80% of the 4 billion projected increase in world population by 2100 comes from 37 Mid-African Countries (MACs), caused mostly by slow declines in Total Fertility Rate (TFR). Historically, TFR has declined in response to increases in wellbeing associated with economic development. We show that, when Infant Survival Rate (ISR, a proxy for wellbeing) has increased, MAC fertility has declined at the same rate, in relation to ISR, as it did in 61 comparable Other Developing Countries (ODCs) wh ...[more]

PMID: 30208044

Similar Datasets

Standing up for health - improving mental wellbeing during COVID-19 isolation by reducing sedentary behaviour.

Project description:The global COVID-19 outbreak and its management are disrupting ways of life and increasing the risk of poor mental and physical health for many. The restrictions on movement have made some forms of physical activity harder to achieve and increased the chances of more sedentary behaviour. Independent of exercise taken, sedentary behaviour can have a negative impact upon mental health, especially by lowering mood. We suggest evidence-based ways of reducing sedentary behaviour with commentary on how they may be adapted for life at home. These include: ways to use external cues, moving more frequently, maximising movement whilst waiting, reallocating time, workstation alternatives, restructuring the physical environment and recruiting help from others. At a time in which our mental and physical health needs are more critical than ever, the relationship between sedentary behaviour and low mood is of particular importance. The current situation represents a good opportunity for us all to change habits to implement a less sedentary lifestyle, for now and the future. This can start with changes we can make at home during lockdown.

| S-EPMC7422799 | biostudies-literature

Improving population health by reducing poverty: New York's Earned Income Tax Credit.

Project description:Despite the established relationship between adverse health outcomes and low socioeconomic status, researchers rarely test the link between health improvements and poverty-alleviating economic policies. New research, however, links individual-level health improvements to the Earned Income Tax Credit (EITC), a broad-based income support policy. We build on these findings by examining whether the EITC has ecological, neighborhood-level health effects. We use a difference-in-difference analysis to measure child health outcomes in 90 low- and middle- income neighborhoods before and after the expansion of New York State and New York City's EITC policy between 1997-2010. Our study takes advantage of the relatively exogenous source of income variation supplied by the EITC-legislative changes to EITC policy parameters. This feature minimizes the endogeneity problem in studying the relationship between income and health. Our estimates link a 15-percentage-point increase in EITC benefit rates to a 0.45 percentage-point reduction in the low birthweight rate. We do not observe any measurable link between EITC benefits and prenatal health or asthma-related pediatric hospitalization. The magnitude of the EITC's impact on low birthweight rates suggests ecological effects, and an additional channel through which anti-poverty measures can serve as public health interventions.

| S-EPMC5769044 | biostudies-literature

Improving rice population productivity by reducing nitrogen rate and increasing plant density.

Project description:In terms of tillering potential, the aboveground portions of rice are significantly influenced by the nitrogen level (NL) and transplant density (TD). To obtain a suitable combination of NL and TD, five NLs (0, 90, 180, 270 and 360 kg ha-1) and two TDs [high density (HD), 32.5×104 hills ha-1; low density (LD), 25.5×104 hills ha-1] were used in the rice experiments during 2012 to 2014, in Jiangsu, China. The results showed the highest grain yield of rice obtained at HD and LD when N supply was 180 and 270 kg ha-1, respectively. That's because there are more tillers per unit area, a larger leaf biomass fraction of total aboveground biomass, a larger leaf area index (LAI) and a larger canopy photosynthesis potential (CPP) at HD. It can be concluded that, higher rice planting densities resulted in less N inputs, while more N is needed to improve single plant actual tiller ability under low density to offset the reduced planting density. When the NL was more than 180 kg ha-1, the actual tillering ability of a single plant at LD was 20% more than that at HD. Based on these results, the supply of 1 kg N can be replaced by adding approximately 1000 planting hills per hectare. Therefore, adjusting the transplant density could be an efficient method to reduce the amount of nitrogen fertilizer and increase the nitrogen fertilizer use efficiency, which is very conducive to the sustainable development of agriculture.

| S-EPMC5540556 | biostudies-literature

Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use.

Project description:The market for biotherapeutic monoclonal antibodies (mAbs) is large and is growing rapidly. However, attrition poses a significant challenge for the development of mAbs, and for biopharmaceuticals in general, with large associated costs in resource and animal use. Termination of candidate mAbs may occur due to poor translation from preclinical models to human safety. It is critical that the industry addresses this problem to maintain productivity. Though attrition poses a significant challenge for pharmaceuticals in general, there are specific challenges related to the development of antibody-based products. Due to species specificity, non-human primates (NHP) are frequently the only pharmacologically relevant species for nonclinical safety and toxicology testing for the majority of antibody-based products, and therefore, as more mAbs are developed, increased NHP use is anticipated. The integration of new and emerging in vitro and in silico technologies, e.g., cell- and tissue-based approaches, systems pharmacology and modeling, have the potential to improve the human safety prediction and the therapeutic mAb development process, while reducing and refining animal use simultaneously. In 2014, to engage in open discussion about the challenges and opportunities for the future of mAb development, a workshop was held with over 60 regulators and experts in drug development, mechanistic toxicology and emerging technologies to discuss this issue. The workshop used industry case-studies to discuss the value of the in vivo studies and identify opportunities for in vitro technologies in human safety assessment. From these and continuing discussions it is clear that there are opportunities to improve safety assessment in mAb development using non-animal technologies, potentially reducing future attrition, and there is a shared desire to reduce animal use through minimised study design and reduced numbers of studies.

| S-EPMC5524158 | biostudies-other

Population genomics of the Viking world

Project description:Population genomics of the Viking world

| PRJEB37976 | ENA

N2O-reducing population in anaerobic digestate for next-generation biorest

Project description:Anaerobic digestion (AD) is a core technology in management of urban organic wastes, converting a fraction of the organic carbon to methane and the residual digestate, the biorest, have a great potential to become a major organic fertilizer for agricultural soils in the future. At the same time, mitigation of N2O-emissions from the agricultural soils is needed to reduce the climate forcing by food production. Our goal was therefore to enrich for N2O reducing bacteria in AD digestates prior to fertilization, and in this way provide an avenue for large-scale and low-cost cultivation of strongly N2O reducing bacteria which can be directly introduced to agricultural soils in large enough volumes to alter the fate of nitrogen in the soils. Gas kinetics and meta-omics (metagenomics and metaproteomics) analyses of the N2O enriched digestates identified populations of N2O respiring organisms that grew by harvesting fermentation intermediates of the methanogenic consortium.

2022-02-16 | PXD022030 | Pride

Future world cancer death rate prediction

Project description:Cancer is a worldwide illness that causes significant morbidity and death and imposes an immense cost on global public health. Modelling such a phenomenon is complex because of the non-stationarity and complexity of cancer waves. Apply modern novel statistical methods directly to raw clinical data. To estimate extreme cancer death rate likelihood at any period in any location of interest. Traditional statistical methodologies that deal with temporal observations of multi-regional processes cannot adequately deal with substantial regional dimensionality and cross-correlation of various regional variables. Setting: multicenter, population-based, medical survey data-based biostatistical approach. Due to the non-stationarity and complicated nature of cancer, it is challenging to model such a phenomenon. This paper offers a unique bio-system dependability technique suited for multi-regional environmental and health systems. When monitored over a significant period, it yields a reliable long-term projection of the chance of an exceptional cancer mortality rate. Traditional statistical approaches dealing with temporal observations of multi-regional processes cannot effectively deal with large regional dimensionality and cross-correlation between multiple regional data. The provided approach may be employed in numerous public health applications, depending on their clinical survey data.

| S-EPMC9822976 | biostudies-literature

Editorial: Improving Wellbeing in Patients With Chronic Conditions: Theory, Evidence, and Opportunities.

Project description: Not available

| S-EPMC8964137 | biostudies-literature

Reducing myocardial infarct size: challenges and future opportunities.

Project description:Despite prompt reperfusion by primary percutaneous coronary intervention (PPCI), the mortality and morbidity of patients presenting with an acute ST-segment elevation myocardial infarction (STEMI) remain significant with 9% death and 10% heart failure at 1?year. In these patients, one important neglected therapeutic target is 'myocardial reperfusion injury', a term given to the cardiomyocyte death and microvascular dysfunction which occurs on reperfusing ischaemic myocardium. A number of cardioprotective therapies (both mechanical and pharmacological), which are known to target myocardial reperfusion injury, have been shown to reduce myocardial infarct (MI) size in small proof-of-concept clinical studies-however, being able to demonstrate improved clinical outcomes has been elusive. In this article, we review the challenges facing clinical cardioprotection research, and highlight future therapies for reducing MI size and preventing heart failure in patients presenting with STEMI at risk of myocardial reperfusion injury.

| S-EPMC4789695 | biostudies-literature

Warfarin prescription and administration: reducing the delay, improving the safety.

Project description:Warfarin is frequently administered to hospital patients. The prescription and administration of this medication are particularly susceptible to error. Factors contributing to this include the narrow therapeutic index, patient-specific target range, and the need for regular INR monitoring. NICE guidelines state that warfarin should be given at the same time every day and the Bristol Royal Infirmary guidelines are warfarin to be given at 14:00. The 14:00 dosing ensures standardisation of administration; poor adherence to this recommendation may cause patient harm. We noticed that many warfarin doses were often given outside of maximal staffing hours and it was often left to the on call doctor to prescribe warfarin at erratic and inconsistent times. Our primary aim was to reduce the number of adverse outcomes associated with warfarin prescription and administration. We targeted two system measures: the proportion of warfarin administrations occurring within an hour of the 14:00 prescription and the proportion of INR results outside target range. We employed the model for improvement and carried out our project across seven acute medical wards. Baseline data showed that only 24% of doses were being given within an hour of the recommended time and 64% of doses were being given after 17:00 during minimal staffing hours. We successfully introduced a warfarin box within our trust which demonstrated an improvement in warfarin administration from 24% of patients receiving their warfarin within an hour of 14:00 to 49% and this was subsequently associated with a reduction in INRs above target range (23% to 9%).

| S-EPMC4645946 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data